Follow the 한올바이오파마 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 한올바이오파마 has recorded 37 public disclosures. The latest transaction was disclosed on 1 July 2026 (Other). Among the most active insiders: 국민연금공단. The full history is openly available.
37
Insider Decl.
0
Thresholds
·
9 ops.
Buy Volume
·
11 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Hanall Biopharma is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments for various diseases.